179 related articles for article (PubMed ID: 8839984)
1. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer.
Kos J; Smid A; Krasovec M; Svetic B; Lenarcic B; Vrhovec I; Skrk J; Turk V
Biol Chem Hoppe Seyler; 1995 Jul; 376(7):401-5. PubMed ID: 7576236
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma.
Smid L; Strojan P; Budihna M; Skrk J; Vrhovec I; Zargi M; Kos J
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S150-3. PubMed ID: 9065652
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Kos J; Skrk J
Clin Cancer Res; 2000 Mar; 6(3):1052-62. PubMed ID: 10741734
[TBL] [Abstract][Full Text] [Related]
5. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.
Levicar N; Kos J; Blejec A; Golouh R; Vrhovec I; Frkovic-Grazio S; Lah TT
Cancer Detect Prev; 2002; 26(1):42-9. PubMed ID: 12088202
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic profile of cysteine proteases and inhibitors determines tumor cell phenotype in squamous cell carcinoma of the head and neck.
Strojan P; Aničin A; Svetic B; Šmid L; Kos J
Int J Biol Markers; 2011; 26(4):247-54. PubMed ID: 22139645
[TBL] [Abstract][Full Text] [Related]
7. Tissue Levels of Stefin A and Stefin B in Hepatocellular Carcinoma.
Lin YY; Chen ZW; Lin ZP; Lin LB; Yang XM; Xu LY; Xie Q
Anat Rec (Hoboken); 2016 Apr; 299(4):428-38. PubMed ID: 26753874
[TBL] [Abstract][Full Text] [Related]
8. Serum concentration and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma.
Cimerman N; Mesko Brguljan P; Krasovec M; Suskovic S; Kos J
Clin Chim Acta; 2001 Aug; 310(2):113-22. PubMed ID: 11498076
[TBL] [Abstract][Full Text] [Related]
9. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.
Lenarcic B; Krizaj I; Zunec P; Turk V
FEBS Lett; 1996 Oct; 395(2-3):113-8. PubMed ID: 8898076
[TBL] [Abstract][Full Text] [Related]
10. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
[TBL] [Abstract][Full Text] [Related]
11. Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study.
Strojan P; Oblak I; Gale N; Smid L; Kos J
Histopathology; 2008 Nov; 53(5):612-4. PubMed ID: 18983473
[No Abstract] [Full Text] [Related]
12. Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue.
Ebert E; Werle B; Jülke B; Kopitar-Jerala N; Kos J; Lah T; Abrahamson M; Spiess E; Ebert W
Adv Exp Med Biol; 1997; 421():259-65. PubMed ID: 9330706
[TBL] [Abstract][Full Text] [Related]
13. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma.
Lah TT; Kokalj-Kunovar M; Strukelj B; Pungercar J; Barlic-Maganja D; Drobnic-Kosorok M; Kastelic L; Babnik J; Golouh R; Turk V
Int J Cancer; 1992 Jan; 50(1):36-44. PubMed ID: 1728611
[TBL] [Abstract][Full Text] [Related]
14. Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.
Zajc I; Sever N; Bervar A; Lah TT
Cancer Lett; 2002 Dec; 187(1-2):185-90. PubMed ID: 12359367
[TBL] [Abstract][Full Text] [Related]
15. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
[TBL] [Abstract][Full Text] [Related]
16. Role of cathepsins and cystatins in patients with recurrent miscarriage.
Nakanishi T; Ozaki Y; Blomgren K; Tateyama H; Sugiura-Ogasawara M; Suzumori K
Mol Hum Reprod; 2005 May; 11(5):351-5. PubMed ID: 15863450
[TBL] [Abstract][Full Text] [Related]
17. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
[TBL] [Abstract][Full Text] [Related]
18. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
19. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck.
Strojan P; Budihna M; Smid L; Svetic B; Vrhovec I; Skrk J
Neoplasma; 2001; 48(1):66-71. PubMed ID: 11327540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]